Holen Sie sich die Stockscreener-App
47.67
1.59%
-0.77
Schlusskurs vom Vortag:
$48.44
Offen:
$48.22
24-Stunden-Volumen:
1.39M
Relative Volume:
0.57
Marktkapitalisierung:
$7.24B
Einnahmen:
$3.44B
Nettoeinkommen (Verlust:
$75.20M
KGV:
90.99
EPS:
0.5239
Netto-Cashflow:
$49.30M
1W Leistung:
-4.35%
1M Leistung:
-0.71%
6M Leistung:
+13.66%
1J Leistung:
-14.86%
1-Tages-Spanne:
$47.63
$49.49
1-Wochen-Bereich:
$47.63
$53.50
52-Wochen-Spanne:
$28.53
$59.40
Bruker Corp Stock (BRKR) Company Profile
Firmenname
Bruker Corp
Sektor
Branche
Telefon
978663-3660
Adresse
40 MANNING RD, BILLERICA, MA
Vergleichen Sie BRKR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
47.67 | 7.36B | 3.44B | 75.20M | 49.30M | 0.5239 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-10 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-09 | Eingeleitet | Goldman | Sell |
| 2025-11-20 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-12-19 | Eingeleitet | Guggenheim | Buy |
| 2024-12-10 | Eingeleitet | UBS | Neutral |
| 2024-12-05 | Hochstufung | Goldman | Sell → Neutral |
| 2024-10-15 | Eingeleitet | Barclays | Overweight |
| 2024-09-30 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-02-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2022-10-21 | Eingeleitet | UBS | Buy |
| 2022-08-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-06-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2021-02-05 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | Eingeleitet | Goldman | Sell |
| 2020-11-16 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2020-04-02 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | Herabstufung | Needham | Strong Buy → Hold |
| 2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Hochstufung | Goldman | Sell → Neutral |
| 2019-06-24 | Bestätigt | Needham | Strong Buy |
| 2019-06-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
| 2019-05-06 | Bestätigt | Needham | Strong Buy |
| 2019-05-03 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | Hochstufung | UBS | Sell → Neutral |
| 2019-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-02-12 | Bestätigt | BTIG Research | Buy |
| 2019-01-03 | Eingeleitet | Needham | Strong Buy |
Alle ansehen
Bruker Corp Aktie (BRKR) Neueste Nachrichten
Levels Update: Will Bruker Corporation stock recover after earningsJuly 2025 Rallies & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Eclipse Bioinnovations, Inc. acquired Terrain Biosciences, Inc. from Magnetic Ventures and Bruker Corporation. - marketscreener.com
Bruker Corp (BRKR) Shares Down 2.98% on Jan 26 - GuruFocus
Guggenheim Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $58 - 富途牛牛
Stocks To Watch: Bruker Sees Relative Strength Rating Rise To 82 - Investor's Business Daily
Bruker Corporation (BRKR): A Bull Case Theory - Finviz
Revenues Working Against Bruker Corporation's (NASDAQ:BRKR) Share Price - 富途资讯
SG Americas Securities LLC Has $1.37 Million Stake in Bruker Corporation $BRKR - MarketBeat
Assessing Bruker (BRKR) Valuation After Recent Share Price Rebound And Conflicting Fair Value Signals - Yahoo Finance
Bruker (NASDAQ:BRKR) VP Sells $98,400.00 in Stock - MarketBeat
Citigroup Boosts Bruker (BRKR) Price Target, Maintains Neutral R - GuruFocus
Citi Maintains Bruker Corp(BRKR.US) With Hold Rating, Raises Target Price to $53 - 富途资讯
September 18th Options Now Available For Bruker (BRKR) - Nasdaq
Mark Munch Sells 7,000 Shares of Bruker (NASDAQ:BRKR) Stock - MarketBeat
Bruker (NASDAQ:BRKR) Stock Price Down 5.8%Should You Sell? - MarketBeat
Why Bruker (BRKR) Shares Are Plunging Today - Finviz
Silver Jumps To $89 After Soft CPI, JPMorgan Falls 3%: What's Moving Markets Tuesday? - Benzinga
Bruker Corp (BRKR) Shares Down 6.48% on Jan 13 - GuruFocus
BofA Securities Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $60 - 富途资讯
Bruker Teases 2026 Margin Surge, $120M Cost Cuts and Double-Digit EPS Growth After Rough 2025 - MarketBeat
Bruker (BRKR) Sets Positive Financial Outlook for 2025 and 2026 - GuruFocus
Bruker (BRKR) Projects Modest Revenue Growth and EPS Increase fo - GuruFocus
Bruker Corp expects 2026 organic revenue growth flat to low-single digits - marketscreener.com
Bruker Corp Expects 2026 Organic Revenue Growth Flat To Low-Single Digits - TradingView
Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for MRI - marketscreener.com
Bruker secures $500m in MRI superconductor supply agreements globally - Yahoo Finance
Bruker Corporation to Present at the J.P. Morgan Healthcare Conference - 富途牛牛
Can Bruker Corporation stock maintain growth trajectoryQuarterly Market Summary & Free Low Drawdown Momentum Trade Ideas - Улправда
Bruker (BRKR) Is Up 13.2% After Securing US$500M MRI Superconductor Deals Has The Bull Case Changed? - Yahoo Finance
Why Is Bruker Stock Gaining Friday?Bruker (NASDAQ:BRKR) - Benzinga
Bruker (BRKR) Secures $500M in Multi-Year Superconductor Agreeme - GuruFocus
Bruker Unit Receives $500 Million in Orders for Superconductors - marketscreener.com
Bruker secures $500 million in superconductor supply deals for MRI systems - Investing.com
Bruker acquires additional 60% stake in Tofwerk, terms undisclosed - Yahoo Finance
Will Bruker Corporation stock outperform growth indexesMarket Trend Summary & Weekly Return Optimization Alerts - Улправда
Will Bruker Corporation (BKD) stock outperform foreign stocksJuly 2025 Institutional & Pattern Based Trade Signal System - ulpravda.ru
Is Bruker Corporation stock a defensive play in 2025Market Performance Summary & Risk Controlled Stock Pick Alerts - ulpravda.ru
Bruker acquires remaining 60% stake in TOFWERK for full ownership By Investing.com - Investing.com Canada
Bruker Consolidates Ownership of TOFWERK in Expansion of Mass Spectrometry Portfolio into New Applied Markets - Chartmill
Bruker acquires remaining 60% stake in TOFWERK for full ownership - Investing.com
Is Bruker (BRKR) Pricing Reflecting Its Life Sciences Role And Mixed Valuation Signals? - Yahoo Finance
TD Cowen Maintains Bruker Corp(BRKR.US) With Hold Rating, Raises Target Price to $53 - 富途牛牛
Bruker Corporation $BRKR Shares Bought by Vaughan Nelson Investment Management L.P. - MarketBeat
How to listen in as Bruker joins J.P. Morgan's big health event - Stock Titan
Bruker Meets 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily
Bruker (BRKR) Is Up 7.9% After Winning €35 Million ELI-NP Order In Romania - simplywall.st
Winners And Losers Of Q3: Bruker (NASDAQ:BRKR) Vs The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
Guggenheim Maintains Bruker Corp(BRKR.US) With Buy Rating, Announces Target Price $53 - 富途牛牛
Why Bruker (BRKR) Stock Is Up Today - Finviz
AbCellera settles patent litigation with Bruker over microfluidic device tech - MSN
Bruker (BRKR) Receives Analyst Rating and Price Target Upgrade f - GuruFocus
Finanzdaten der Bruker Corp-Aktie (BRKR)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):